[
  {
    "title": "九典制药：非洛地平片获药品注册证书",
    "href": "http://stock.jrj.com.cn/2023/01/05170937261584.shtml",
    "datetime": "2023-01-05 17:09:40",
    "code": "300705"
  },
  {
    "title": "西部证券保荐九典制药可转债顺利过审",
    "href": "http://stock.jrj.com.cn/2022/12/26135037237690.shtml",
    "datetime": "2022-12-26 13:50:57",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：发行可转债申请获深交所创业板上市委员会审核通过",
    "href": "http://stock.jrj.com.cn/2022/12/23202537235300.shtml",
    "datetime": "2022-12-23 20:25:43",
    "code": "300705"
  },
  {
    "title": "九典制药：最近公司洛索洛芬纳片的销量有较明显的提升",
    "href": "http://stock.jrj.com.cn/2022/12/19142137222240.shtml",
    "datetime": "2022-12-19 14:21:37",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：总经理郑霞辉、财务总监熊英完成减持合计74.645万股",
    "href": "http://stock.jrj.com.cn/2022/11/21202637155527.shtml",
    "datetime": "2022-11-21 20:26:42",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：拟于11月28日提前赎回全部九典转债",
    "href": "http://stock.jrj.com.cn/2022/11/04191037113840.shtml",
    "datetime": "2022-11-04 19:10:22",
    "code": "300705"
  },
  {
    "title": "九典制药一款药品拟中选广东省阿比特龙等药品集中带量采购",
    "href": "http://stock.jrj.com.cn/2022/11/01193237104297.shtml",
    "datetime": "2022-11-01 19:32:40",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：3名股东拟合计减持不超2.3%的股份",
    "href": "http://stock.jrj.com.cn/2022/11/01192937104274.shtml",
    "datetime": "2022-11-01 19:29:55",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：铝碳酸镁咀嚼片拟中选广东省阿比特龙等药品集中带量采购",
    "href": "http://stock.jrj.com.cn/2022/11/01192637104278.shtml",
    "datetime": "2022-11-01 19:26:42",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：乙酰半胱氨酸颗粒获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/10/14202937057317.shtml",
    "datetime": "2022-10-14 20:29:23",
    "code": "300705"
  },
  {
    "title": "九典制药：发行可转债申请获深交所受理",
    "href": "http://stock.jrj.com.cn/2022/09/23144337016919.shtml",
    "datetime": "2022-09-23 14:43:47",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：可转债发行申请获深交所受理",
    "href": "http://stock.jrj.com.cn/2022/09/23114937016536.shtml",
    "datetime": "2022-09-23 11:49:54",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：瑞舒伐他汀钙片拟中选渝川蒙鄂滇藏陕宁联盟地区集采",
    "href": "http://stock.jrj.com.cn/2022/09/13175936991751.shtml",
    "datetime": "2022-09-13 17:59:35",
    "code": "300705"
  },
  {
    "title": "九典制药：瑞舒伐他汀钙片拟中选渝川蒙鄂滇藏陕宁联盟地区的集中带量采购",
    "href": "http://stock.jrj.com.cn/2022/09/13173136991614.shtml",
    "datetime": "2022-09-13 17:31:12",
    "code": "300705"
  },
  {
    "title": "九典制药：公司产品瑞舒伐他汀钙片拟中选渝川蒙鄂滇藏陕宁联盟地区的集中带量采购",
    "href": "http://stock.jrj.com.cn/2022/09/13172436991576.shtml",
    "datetime": "2022-09-13 17:24:14",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：盐酸普拉克索缓释片获批上市",
    "href": "http://stock.jrj.com.cn/2022/09/09163636986640.shtml",
    "datetime": "2022-09-09 16:36:16",
    "code": "300705"
  },
  {
    "title": "九典制药：盐酸普拉克索缓释片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/09/09163436986592.shtml",
    "datetime": "2022-09-09 16:34:16",
    "code": "300705"
  },
  {
    "title": "九典制药上半年营收大增四成 超前投入研发创新和打造完整产业链双剑齐发",
    "href": "http://stock.jrj.com.cn/2022/08/11093236889470.shtml",
    "datetime": "2022-08-11 09:32:11",
    "code": "300705"
  },
  {
    "title": "九典制药2022年上半年实现净利润1.3亿元：学术推广费4.59亿元 占总营收45%",
    "href": "http://stock.jrj.com.cn/2022/08/09111036882000.shtml",
    "datetime": "2022-08-09 11:10:27",
    "code": "300705"
  },
  {
    "title": "九典制药：2022年半年实现营收10.31亿元，同比增长40.89%",
    "href": "http://stock.jrj.com.cn/2022/08/01113336858496.shtml",
    "datetime": "2022-08-01 11:33:01",
    "code": "300705"
  },
  {
    "title": "A股异动 | 九典制药涨超7%创阶段新高 上半年净利同比增15%",
    "href": "http://stock.jrj.com.cn/2022/08/01105936858379.shtml",
    "datetime": "2022-08-01 10:59:32",
    "code": "300705"
  },
  {
    "title": "九典制药2022年上半年净利1.3亿同比增长15.02% 销量持续上升",
    "href": "http://stock.jrj.com.cn/2022/07/29231136855781.shtml",
    "datetime": "2022-07-29 23:11:38",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：上半年净利润增15.02%至1.298亿元",
    "href": "http://stock.jrj.com.cn/2022/07/29202236855269.shtml",
    "datetime": "2022-07-29 20:22:10",
    "code": "300705"
  },
  {
    "title": "九典制药：公司产品依巴斯汀片拟中选第七批全国药品集采",
    "href": "http://stock.jrj.com.cn/2022/07/14114236810535.shtml",
    "datetime": "2022-07-14 11:42:30",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：依巴斯汀片拟中选第七批第七批",
    "href": "http://stock.jrj.com.cn/2022/07/13171736807789.shtml",
    "datetime": "2022-07-13 17:17:24",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：铝碳酸镁咀嚼片拟中选江苏、甘肃两省集采",
    "href": "http://stock.jrj.com.cn/2022/07/08163836794687.shtml",
    "datetime": "2022-07-08 16:38:25",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：总经理郑霞辉及财务总监熊英拟合计减持不超75.6059万股",
    "href": "http://stock.jrj.com.cn/2022/06/24203136758004.shtml",
    "datetime": "2022-06-24 20:31:02",
    "code": "300705"
  },
  {
    "title": "A股异动 | 九典制药(300705.SZ)涨近6% 琥珀酸亚铁片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/06/22143836749398.shtml",
    "datetime": "2022-06-22 14:38:08",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：琥珀酸亚铁片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2022/06/21172736746728.shtml",
    "datetime": "2022-06-21 17:27:27",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：改良型新药PDX-03获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/06/15171936731517.shtml",
    "datetime": "2022-06-15 17:19:58",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：铝碳酸镁咀嚼片拟中选相关集中带量采购",
    "href": "http://stock.jrj.com.cn/2022/06/02175536701121.shtml",
    "datetime": "2022-06-02 17:55:13",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：拟发行不超3.7亿元可转债 全部用于高端制剂研发产业园口服固体制剂项目",
    "href": "http://stock.jrj.com.cn/2022/06/01193536697989.shtml",
    "datetime": "2022-06-01 19:35:43",
    "code": "300705"
  },
  {
    "title": "九典制药第一大股东朱志宏质押417.72万股 用于个人融资",
    "href": "http://stock.jrj.com.cn/2022/05/25205236678890.shtml",
    "datetime": "2022-05-25 20:52:54",
    "code": "300705"
  },
  {
    "title": "九典制药：持股5%以上股东朱志宏所持417.72万股质押",
    "href": "http://stock.jrj.com.cn/2022/05/25183036678486.shtml",
    "datetime": "2022-05-25 18:30:23",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：朱志宏质押417.72万股",
    "href": "http://stock.jrj.com.cn/2022/05/25170436677916.shtml",
    "datetime": "2022-05-25 17:04:27",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)2021年度权益分派10转4派2.61元 股权登记日为5月26日",
    "href": "http://stock.jrj.com.cn/2022/05/19213236663718.shtml",
    "datetime": "2022-05-19 21:32:31",
    "code": "300705"
  },
  {
    "title": "九典制药2022年第一季度净利5596.59万同比增长20.49% 市场开拓成果逐步显现",
    "href": "http://stock.jrj.com.cn/2022/05/02165036532954.shtml",
    "datetime": "2022-05-02 16:50:41",
    "code": "300705"
  },
  {
    "title": "九典制药2021年净利2.04亿同比增长148.29% 董事长朱志宏薪酬96.22万",
    "href": "http://stock.jrj.com.cn/2022/04/26221336479051.shtml",
    "datetime": "2022-04-26 22:13:15",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)一季度净利润5596.59万元 同比增长20.49%",
    "href": "http://stock.jrj.com.cn/2022/04/26180936476950.shtml",
    "datetime": "2022-04-26 18:09:42",
    "code": "300705"
  },
  {
    "title": "九典制药第一大股东及一致行动人合计质押401.94万股 用于个人融资",
    "href": "http://stock.jrj.com.cn/2022/04/07183636268820.shtml",
    "datetime": "2022-04-07 18:36:13",
    "code": "300705"
  },
  {
    "title": "A股异动 | 九典制药(300705.SZ)涨8% 产品拟中选广东联盟集采",
    "href": "http://stock.jrj.com.cn/2022/03/11141034813418.shtml",
    "datetime": "2022-03-11 14:10:35",
    "code": "300705"
  },
  {
    "title": "九典制药：参加广东联盟双氯芬酸等药品集中带量采购拟中选",
    "href": "http://stock.jrj.com.cn/2022/03/11134734813359.shtml",
    "datetime": "2022-03-11 13:47:31",
    "code": "300705"
  },
  {
    "title": "九典制药：公司产品洛索洛芬钠凝胶贴膏拟中选广东联盟药品集采",
    "href": "http://stock.jrj.com.cn/2022/03/11133934813357.shtml",
    "datetime": "2022-03-11 13:39:39",
    "code": "300705"
  },
  {
    "title": "午间公告：九典制药洛索洛芬钠凝胶贴膏拟中选广东联盟集采",
    "href": "http://stock.jrj.com.cn/2022/03/11121534813142.shtml",
    "datetime": "2022-03-11 12:15:33",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：洛索洛芬钠凝胶贴膏拟中选广东联盟集采",
    "href": "http://stock.jrj.com.cn/2022/03/11115234813072.shtml",
    "datetime": "2022-03-11 11:52:31",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)拟推530万股限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/03/07184634538394.shtml",
    "datetime": "2022-03-07 18:46:33",
    "code": "300705"
  },
  {
    "title": "九典制药扣非净利润预增超1.6倍 研发投入增五成",
    "href": "http://stock.jrj.com.cn/2022/01/31081734261403.shtml",
    "datetime": "2022-01-31 08:17:00",
    "code": "300705"
  },
  {
    "title": "九典制药2021年预计净利1.95亿-2.18亿同比增长137%-165% 新增技术转让服务收入",
    "href": "http://stock.jrj.com.cn/2022/01/30051034258392.shtml",
    "datetime": "2022-01-30 05:10:54",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：外用非甾体类抗炎药PDX-02获批临床",
    "href": "http://stock.jrj.com.cn/2022/01/17163134164907.shtml",
    "datetime": "2022-01-17 16:31:28",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：将投资1.57亿元建高端制剂研发产业园建设项目(一期)",
    "href": "http://stock.jrj.com.cn/2022/01/11204534147546.shtml",
    "datetime": "2022-01-11 20:45:13",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：持股5%以上股东段立新解质280.12万股",
    "href": "http://stock.jrj.com.cn/2021/12/29160034081180.shtml",
    "datetime": "2021-12-29 16:00:13",
    "code": "300705"
  },
  {
    "title": "九典制药：收到浏阳市财政局拨付的政府补助资金868万元",
    "href": "http://stock.jrj.com.cn/2021/12/28141734076076.shtml",
    "datetime": "2021-12-28 14:17:15",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：近日收到政府补助868万元",
    "href": "http://stock.jrj.com.cn/2021/12/28125634075740.shtml",
    "datetime": "2021-12-28 12:56:50",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：总经理郑霞辉减持到期未减持",
    "href": "http://stock.jrj.com.cn/2021/11/26190033924615.shtml",
    "datetime": "2021-11-26 19:00:32",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：段立新解除质押224.09万股",
    "href": "http://stock.jrj.com.cn/2021/11/04203433814000.shtml",
    "datetime": "2021-11-04 20:34:15",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)第三季度净利润5639.50万元 同比增长152.17%",
    "href": "http://stock.jrj.com.cn/2021/10/25165033747676.shtml",
    "datetime": "2021-10-25 16:50:27",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：“九典转债”自10月8日起开始转股",
    "href": "http://stock.jrj.com.cn/2021/09/28214933532737.shtml",
    "datetime": "2021-09-28 21:49:59",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：收到产品“奥硝唑片”的药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2021/09/14203933435367.shtml",
    "datetime": "2021-09-14 20:39:59",
    "code": "300705"
  },
  {
    "title": "九典制药2021年半年度净利1.13亿元 同比净利增加243.72%",
    "href": "http://stock.jrj.com.cn/2021/08/11122633236712.shtml",
    "datetime": "2021-08-11 12:26:51",
    "code": "300705"
  },
  {
    "title": "九典制药2021年上半年净利1.13亿增长243.72% 新增技术转让业务",
    "href": "http://stock.jrj.com.cn/2021/08/09210733227299.shtml",
    "datetime": "2021-08-09 21:07:53",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：上半年净利增243.72%至1.13亿元",
    "href": "http://stock.jrj.com.cn/2021/08/09171233225980.shtml",
    "datetime": "2021-08-09 17:12:52",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：瑞舒伐他汀钙片获批上市",
    "href": "http://stock.jrj.com.cn/2021/07/23171733140847.shtml",
    "datetime": "2021-07-23 17:17:27",
    "code": "300705"
  },
  {
    "title": "九典制药：连续三个交易日收盘价格跌幅偏离值达到30%",
    "href": "http://stock.jrj.com.cn/2021/07/21193033131197.shtml",
    "datetime": "2021-07-21 19:30:46",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：洛索洛芬钠凝胶贴膏拟纳入联盟地区集团带量采购范围",
    "href": "http://stock.jrj.com.cn/2021/07/21192433131100.shtml",
    "datetime": "2021-07-21 19:24:43",
    "code": "300705"
  },
  {
    "title": "【龙虎榜】九典制药7月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/07/21180433130754.shtml",
    "datetime": "2021-07-21 18:04:40",
    "code": "300705"
  },
  {
    "title": "九典制药核心药品列入集采范围 股价“深蹲”30%",
    "href": "http://stock.jrj.com.cn/2021/07/20155533129344.shtml",
    "datetime": "2021-07-20 15:55:09",
    "code": "300705"
  },
  {
    "title": "【龙虎榜】九典制药7月19日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/07/19180533120001.shtml",
    "datetime": "2021-07-19 18:05:14",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：获得依巴斯汀片的药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/07/05220133049332.shtml",
    "datetime": "2021-07-05 22:01:43",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：枸橼酸氢钾钠颗粒拟中标第五轮集采",
    "href": "http://stock.jrj.com.cn/2021/06/24114532988608.shtml",
    "datetime": "2021-06-24 11:45:23",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：奥硝唑片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/31090632847217.shtml",
    "datetime": "2021-05-31 09:06:31",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)2020年度权益分派10派0.43元 股权登记日为5月18日",
    "href": "http://stock.jrj.com.cn/2021/05/11200932737017.shtml",
    "datetime": "2021-05-11 20:09:59",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：董事、总经理郑霞辉拟减持不超43.5435万股",
    "href": "http://stock.jrj.com.cn/2021/04/30161732487469.shtml",
    "datetime": "2021-04-30 16:17:26",
    "code": "300705"
  },
  {
    "title": "A股异动 | 九典制药(300705.SZ)涨近7% 一季度净利大增叠加券商看好",
    "href": "http://stock.jrj.com.cn/2021/04/30142632486799.shtml",
    "datetime": "2021-04-30 14:26:51",
    "code": "300705"
  },
  {
    "title": "九典制药：公司本次发行的可转换公司债券属于《证券法》规定的其他具有股权性质的证券",
    "href": "http://stock.jrj.com.cn/2021/04/26100732452201.shtml",
    "datetime": "2021-04-26 10:07:43",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：2.7亿元可转债将于4月23日起在深交所挂牌交易",
    "href": "http://stock.jrj.com.cn/2021/04/20171232410559.shtml",
    "datetime": "2021-04-20 17:12:23",
    "code": "300705"
  },
  {
    "title": "九典制药：公司奥硝唑和塞克硝唑的年产能合计是300吨",
    "href": "http://stock.jrj.com.cn/2021/04/19191632403596.shtml",
    "datetime": "2021-04-19 19:16:08",
    "code": "300705"
  },
  {
    "title": "九典制药：公司产品需要面向药品生产企业、医院、药店等众多客户进行推广",
    "href": "http://stock.jrj.com.cn/2021/04/19134532401148.shtml",
    "datetime": "2021-04-19 13:45:39",
    "code": "300705"
  },
  {
    "title": "九典制药2020年净利增长49.38% 董事长朱志宏薪酬91.39万",
    "href": "http://stock.jrj.com.cn/2021/04/18100832392633.shtml",
    "datetime": "2021-04-18 10:08:25",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)2020年度净利润升49.38%至8225.98万元 拟10派0.43元",
    "href": "http://stock.jrj.com.cn/2021/04/16202132388543.shtml",
    "datetime": "2021-04-16 20:21:38",
    "code": "300705"
  },
  {
    "title": "九典制药：公司将充分把握国外疫情处于高发期的时间窗口",
    "href": "http://stock.jrj.com.cn/2021/04/12134832357298.shtml",
    "datetime": "2021-04-12 13:48:03",
    "code": "300705"
  },
  {
    "title": "九典制药：目前酮洛芬凝胶贴膏（酮洛芬巴布膏）仍然处于审评审批状态中",
    "href": "http://stock.jrj.com.cn/2021/04/12084732355573.shtml",
    "datetime": "2021-04-12 08:47:19",
    "code": "300705"
  },
  {
    "title": "九典制药：公司产品参苓口服液、复方南五加口服液等为国内独家品种",
    "href": "http://stock.jrj.com.cn/2021/04/06143632318861.shtml",
    "datetime": "2021-04-06 14:36:04",
    "code": "300705"
  },
  {
    "title": "募资2.7亿元做强医药主业 九典制药可转债今日发行申购",
    "href": "http://stock.jrj.com.cn/2021/04/01115132264759.shtml",
    "datetime": "2021-04-01 11:51:00",
    "code": "300705"
  },
  {
    "title": "九典制药2020年度净利8027.77万增长45.78% 主营业务收入稳健增长",
    "href": "http://stock.jrj.com.cn/2021/02/28193832040734.shtml",
    "datetime": "2021-02-28 19:38:23",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)业绩快报：2020年净利升45.78%至8027.77万元",
    "href": "http://stock.jrj.com.cn/2021/02/28173532040309.shtml",
    "datetime": "2021-02-28 17:35:55",
    "code": "300705"
  },
  {
    "title": "九典制药业绩快报：2020年度净利润8028万元 同比增长45.78%",
    "href": "http://stock.jrj.com.cn/2021/02/28173132040217.shtml",
    "datetime": "2021-02-28 17:31:26",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)获得政府补助830万元",
    "href": "http://stock.jrj.com.cn/2021/02/22160532006198.shtml",
    "datetime": "2021-02-22 16:05:45",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：两个产品拟中标第四批全国药品集采",
    "href": "http://stock.jrj.com.cn/2021/02/04172431849479.shtml",
    "datetime": "2021-02-04 17:24:44",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：发行可转债申请获证监会同意注册批复",
    "href": "http://stock.jrj.com.cn/2021/01/13162731684455.shtml",
    "datetime": "2021-01-13 16:27:46",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：共有50个品种63个产品品规进入国家医保目录",
    "href": "http://stock.jrj.com.cn/2021/01/11185831671666.shtml",
    "datetime": "2021-01-11 18:58:06",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：铝碳酸镁咀嚼片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/01/11183831671534.shtml",
    "datetime": "2021-01-11 18:38:36",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：泮托拉唑钠肠溶片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/06170431642180.shtml",
    "datetime": "2021-01-06 17:04:38",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：持股5%以上股东段立新解除质押256.38万股",
    "href": "http://stock.jrj.com.cn/2020/12/31165131613002.shtml",
    "datetime": "2020-12-31 16:51:07",
    "code": "300705"
  },
  {
    "title": "九典制药3名股东合计减持387.24万股 套现合计约7650.416万元",
    "href": "http://stock.jrj.com.cn/2020/12/30214331607101.shtml",
    "datetime": "2020-12-30 21:43:53",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：控股股东及其一致行动人、持股5%以上股东段立新减持股份计划实施完毕",
    "href": "http://stock.jrj.com.cn/2020/12/30200831606587.shtml",
    "datetime": "2020-12-30 20:08:10",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)技术中心被认定为第27批国家企业技术中心",
    "href": "http://stock.jrj.com.cn/2020/12/28164931586762.shtml",
    "datetime": "2020-12-28 16:49:31",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：持股5%以上的段立新解质128.19万股",
    "href": "http://stock.jrj.com.cn/2020/12/25195231572158.shtml",
    "datetime": "2020-12-25 19:52:14",
    "code": "300705"
  },
  {
    "title": "九典制药股东郑霞辉减持58.06万股 套现约1220.96万元",
    "href": "http://stock.jrj.com.cn/2020/12/24192031563092.shtml",
    "datetime": "2020-12-24 19:20:34",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：股东郑霞辉累计减持58.06万股 减持计划已实施完毕",
    "href": "http://stock.jrj.com.cn/2020/12/24162631561762.shtml",
    "datetime": "2020-12-24 16:26:57",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：股东段立新解除质押256.38万股",
    "href": "http://stock.jrj.com.cn/2020/12/23164331554248.shtml",
    "datetime": "2020-12-23 16:43:54",
    "code": "300705"
  },
  {
    "title": "九典制药：持股5%以上股东段立新近日减持270万股 占公司总股本比例1.15%",
    "href": "http://stock.jrj.com.cn/2020/12/22180131546736.shtml",
    "datetime": "2020-12-22 18:01:01",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：股东段立新累计减持385万股 减持数量已过半",
    "href": "http://stock.jrj.com.cn/2020/12/14164631487579.shtml",
    "datetime": "2020-12-14 16:46:46",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：股东段立新质押640.95万股及解除质押1540万股",
    "href": "http://stock.jrj.com.cn/2020/12/07204731433177.shtml",
    "datetime": "2020-12-07 20:47:58",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：厄贝沙坦片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/12/07204631433122.shtml",
    "datetime": "2020-12-07 20:46:55",
    "code": "300705"
  },
  {
    "title": "九典制药：股东段立新近日减持290万股 占公司总股本1.24%",
    "href": "http://stock.jrj.com.cn/2020/11/24144231337829.shtml",
    "datetime": "2020-11-24 14:42:09",
    "code": "300705"
  },
  {
    "title": "[九典制药]闪耀第15届中国成长型医药企业发展论坛 我司荣膺金牛奖",
    "href": "http://stock.jrj.com.cn/2020/11/17000031542691.shtml",
    "datetime": "2020-11-17 00:00:00",
    "code": "300705"
  },
  {
    "title": "午间公告集锦：九典制药洛索洛芬钠片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/11/09121931240214.shtml",
    "datetime": "2020-11-09 12:19:57",
    "code": "300705"
  },
  {
    "title": "九典制药：控股股东及其一致行动人、持股5%以上股东拟合计减持不超5%公司股份",
    "href": "http://stock.jrj.com.cn/2020/11/05204231223480.shtml",
    "datetime": "2020-11-05 20:42:00",
    "code": "300705"
  },
  {
    "title": "九典制药2020年前三季度净利5518.60万增长45.78% 借款利息增加",
    "href": "http://stock.jrj.com.cn/2020/10/30091431173242.shtml",
    "datetime": "2020-10-30 09:14:55",
    "code": "300705"
  },
  {
    "title": "[九典制药]2020医药湘军总评榜出炉 九典斩获两项殊荣",
    "href": "http://stock.jrj.com.cn/2020/10/27000031542688.shtml",
    "datetime": "2020-10-27 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药(300705.SZ)：可转债发行申请获深交所审核通过",
    "href": "http://stock.jrj.com.cn/2020/10/21115431099540.shtml",
    "datetime": "2020-10-21 11:54:11",
    "code": "300705"
  },
  {
    "title": "[九典制药]网站改版升级维护公告",
    "href": "http://stock.jrj.com.cn/2020/10/09000031008710.shtml",
    "datetime": "2020-10-09 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药股东李敏减持11.68万股 套现约251.94万元",
    "href": "http://stock.jrj.com.cn/2020/09/30192430868586.shtml",
    "datetime": "2020-09-30 19:24:59",
    "code": "300705"
  },
  {
    "title": "九典制药2020年上半年净利3282万增长15% 调整毛利高的产品在收入结构中占比提高",
    "href": "http://stock.jrj.com.cn/2020/08/22081830562136.shtml",
    "datetime": "2020-08-22 08:18:05",
    "code": "300705"
  },
  {
    "title": "[九典制药]蓄力向上 乘风破浪:九典制药召开半年度工作会议",
    "href": "http://stock.jrj.com.cn/2020/08/07000031542690.shtml",
    "datetime": "2020-08-07 00:00:00",
    "code": "300705"
  },
  {
    "title": "午间公告：九典制药、科创信息高管拟减持公司股份",
    "href": "http://stock.jrj.com.cn/2020/06/17121129948305.shtml",
    "datetime": "2020-06-17 12:11:51",
    "code": "300705"
  },
  {
    "title": "九典制药第一季度盈利711.09万同比下滑31.73% 销售订单减少",
    "href": "http://stock.jrj.com.cn/2020/04/27221129398389.shtml",
    "datetime": "2020-04-27 22:11:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]“ 惠企礼包”送上门 助力我司发展提速",
    "href": "http://stock.jrj.com.cn/2020/04/20000031542687.shtml",
    "datetime": "2020-04-20 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]“惠企礼包”送上门 助力我司发展提速",
    "href": "http://stock.jrj.com.cn/2020/04/20000029328507.shtml",
    "datetime": "2020-04-20 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]“惠企礼包”送上门 助力我司发展提速",
    "href": "http://stock.jrj.com.cn/2020/04/20000030239500.shtml",
    "datetime": "2020-04-20 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药：2019年净利同比降23.50% 拟发行不超2.7亿元可转债",
    "href": "http://stock.jrj.com.cn/2020/04/17210629315744.shtml",
    "datetime": "2020-04-17 21:06:00",
    "code": "300705"
  },
  {
    "title": "九典制药2020年一季度预计净利650万元–810万元 同比下降22.24%-37.60%",
    "href": "http://stock.jrj.com.cn/2020/04/09225229249987.shtml",
    "datetime": "2020-04-09 22:52:48",
    "code": "300705"
  },
  {
    "title": "[九典制药]同心战“疫” 守望相助:公司137万余元药品驰援抗疫一线",
    "href": "http://stock.jrj.com.cn/2020/03/06000031542689.shtml",
    "datetime": "2020-03-06 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]同心战“疫” 守望相助:公司137万余元药品驰援抗疫一线",
    "href": "http://stock.jrj.com.cn/2020/03/06000028967684.shtml",
    "datetime": "2020-03-06 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]同心战“疫” 守望相助:公司137万余元药品驰援抗疫一线",
    "href": "http://stock.jrj.com.cn/2020/03/06000030239505.shtml",
    "datetime": "2020-03-06 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]公司多措并举 确保疫情防控和复工复产两不误",
    "href": "http://stock.jrj.com.cn/2020/03/04000028953165.shtml",
    "datetime": "2020-03-04 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]公司多措并举 确保疫情防控和复工复产两不误",
    "href": "http://stock.jrj.com.cn/2020/03/04000030239501.shtml",
    "datetime": "2020-03-04 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]公司多措并举 确保疫情防控和复工复产两不误",
    "href": "http://stock.jrj.com.cn/2020/03/04000031542686.shtml",
    "datetime": "2020-03-04 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药2019年盈利5710万元下滑21% 研发费用大幅增加",
    "href": "http://stock.jrj.com.cn/2020/02/26192128899122.shtml",
    "datetime": "2020-02-26 19:21:11",
    "code": "300705"
  },
  {
    "title": "九典制药：正在申请医用酒精生产许可",
    "href": "http://stock.jrj.com.cn/2020/02/10092728801002.shtml",
    "datetime": "2020-02-10 09:27:00",
    "code": "300705"
  },
  {
    "title": "九典制药2019年预计净利5000万元-6300万元 同比下降12%-31%",
    "href": "http://stock.jrj.com.cn/2020/01/20190828707577.shtml",
    "datetime": "2020-01-20 19:08:11",
    "code": "300705"
  },
  {
    "title": "九典制药：公司盐酸左西替利嗪片拟中标第二批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/17212528694976.shtml",
    "datetime": "2020-01-17 21:25:18",
    "code": "300705"
  },
  {
    "title": "九典制药副总经理李敏减持15.57万股",
    "href": "http://stock.jrj.com.cn/2019/12/30213828605682.shtml",
    "datetime": "2019-12-30 21:38:21",
    "code": "300705"
  },
  {
    "title": "九典制药及全资子公司今年累计收到政府补贴资金949万元",
    "href": "http://stock.jrj.com.cn/2019/11/23114828441152.shtml",
    "datetime": "2019-11-23 11:48:31",
    "code": "300705"
  },
  {
    "title": "九典制药股东李敏拟减持股份 预计减持不超总股本0.07%",
    "href": "http://stock.jrj.com.cn/2019/11/19181628420483.shtml",
    "datetime": "2019-11-19 18:16:01",
    "code": "300705"
  },
  {
    "title": "九典制药获得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/11/14221228401377.shtml",
    "datetime": "2019-11-14 22:12:02",
    "code": "300705"
  },
  {
    "title": "九典制药第三季度盈利934万 同比下滑43%",
    "href": "http://stock.jrj.com.cn/2019/10/30123228324723.shtml",
    "datetime": "2019-10-30 12:32:20",
    "code": "300705"
  },
  {
    "title": "九典制药全资子公司获得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/10/15212228252300.shtml",
    "datetime": "2019-10-15 21:22:02",
    "code": "300705"
  },
  {
    "title": "九典制药2019前三季度净利3600万-3900万 研发费用大幅度增加",
    "href": "http://stock.jrj.com.cn/2019/10/15092228247842.shtml",
    "datetime": "2019-10-15 09:22:17",
    "code": "300705"
  },
  {
    "title": "[九典制药]湖南九典制药股份有限公司关于污水处理系统的整改方案及整改完成情况的说明",
    "href": "http://stock.jrj.com.cn/2019/10/08000028212390.shtml",
    "datetime": "2019-10-08 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药5名股东合计减持235万股 套现合计约2689万元",
    "href": "http://stock.jrj.com.cn/2019/09/27214228193516.shtml",
    "datetime": "2019-09-27 21:42:31",
    "code": "300705"
  },
  {
    "title": "[九典制药]关爱自闭症儿童 九典制药在行动",
    "href": "http://stock.jrj.com.cn/2019/09/27000030239503.shtml",
    "datetime": "2019-09-27 00:00:00",
    "code": "300705"
  },
  {
    "title": "午后医药制造板块走强 九典制药、盘龙药业涨停",
    "href": "http://stock.jrj.com.cn/2019/09/10133128115823.shtml",
    "datetime": "2019-09-10 13:31:34",
    "code": "300705"
  },
  {
    "title": "医药板块午后持续活跃 九典制药拉升涨停",
    "href": "http://stock.jrj.com.cn/2019/09/10132328115806.shtml",
    "datetime": "2019-09-10 13:23:00",
    "code": "300705"
  },
  {
    "title": "九典制药：琥珀酸亚铁片注册申请处于“审批完毕-待制证”状态",
    "href": "http://stock.jrj.com.cn/2019/09/04180728089822.shtml",
    "datetime": "2019-09-04 18:07:00",
    "code": "300705"
  },
  {
    "title": "九典制药2019年上半年净利2852万 加强营销体系建设与学术推广",
    "href": "http://stock.jrj.com.cn/2019/08/19200427998781.shtml",
    "datetime": "2019-08-19 20:04:00",
    "code": "300705"
  },
  {
    "title": "九典制药预计盈利2800万元左右 与上年同期基本持平",
    "href": "http://stock.jrj.com.cn/2019/07/12205727833978.shtml",
    "datetime": "2019-07-12 20:57:49",
    "code": "300705"
  },
  {
    "title": "[九典制药]湖南省副省长何报翔实地调研九典制药发展情况",
    "href": "http://stock.jrj.com.cn/2019/07/10000027820201.shtml",
    "datetime": "2019-07-10 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]湖南省副省长何报翔实地调研九典制药发展情况",
    "href": "http://stock.jrj.com.cn/2019/07/10000030239516.shtml",
    "datetime": "2019-07-10 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]科技赋能驱动发展!九典制药“国家级博士后科研工作站”授牌成立",
    "href": "http://stock.jrj.com.cn/2019/06/21000027737029.shtml",
    "datetime": "2019-06-21 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]科技赋能驱动发展!九典制药“国家级博士后科研工作站”授牌成立",
    "href": "http://stock.jrj.com.cn/2019/06/21000030239499.shtml",
    "datetime": "2019-06-21 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典制药开展国民经济动员演练 积累实战经验",
    "href": "http://stock.jrj.com.cn/2019/06/14000030239504.shtml",
    "datetime": "2019-06-14 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典制药开展国民经济动员演练 积累实战经验",
    "href": "http://stock.jrj.com.cn/2019/06/14000028064409.shtml",
    "datetime": "2019-06-14 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典制药开展国民经济动员演练 积累实战经验",
    "href": "http://stock.jrj.com.cn/2019/06/14000027704241.shtml",
    "datetime": "2019-06-14 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药：子公司取得原料药、药用辅料生产许可",
    "href": "http://stock.jrj.com.cn/2019/06/11174927687503.shtml",
    "datetime": "2019-06-11 17:49:00",
    "code": "300705"
  },
  {
    "title": "九典制药5股东拟合计减持公司不超过3%股份",
    "href": "http://stock.jrj.com.cn/2019/06/05203827668748.shtml",
    "datetime": "2019-06-05 20:38:48",
    "code": "300705"
  },
  {
    "title": "九典制药：五股东拟合计减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/06/05202527668713.shtml",
    "datetime": "2019-06-05 20:25:06",
    "code": "300705"
  },
  {
    "title": "九典制药：拟将望城生产基地原料药等业务划转至子公司",
    "href": "http://stock.jrj.com.cn/2019/06/04174127663306.shtml",
    "datetime": "2019-06-04 17:41:40",
    "code": "300705"
  },
  {
    "title": "九典制药：望城生产基地原料药等业务划转至子公司",
    "href": "http://stock.jrj.com.cn/2019/06/04173827663308.shtml",
    "datetime": "2019-06-04 17:38:00",
    "code": "300705"
  },
  {
    "title": "九典制药：获得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/05/29172327638039.shtml",
    "datetime": "2019-05-29 17:23:48",
    "code": "300705"
  },
  {
    "title": "[九典制药]企业环境保护验收公示",
    "href": "http://stock.jrj.com.cn/2019/05/22000027606890.shtml",
    "datetime": "2019-05-22 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药去年净利7199万元 同比增长5% 董事长朱志宏年薪为79万元",
    "href": "http://stock.jrj.com.cn/2019/04/11230127369457.shtml",
    "datetime": "2019-04-11 23:01:32",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典制药举行健康号专列首发仪式 品牌建设踏上提速之旅",
    "href": "http://stock.jrj.com.cn/2019/04/08000027350513.shtml",
    "datetime": "2019-04-08 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典制药举行健康号专列首发仪式 品牌建设踏上提速之旅",
    "href": "http://stock.jrj.com.cn/2019/04/08000028064408.shtml",
    "datetime": "2019-04-08 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]浏阳经开区召开2019年经济工作会议 九典制药揽获七项殊荣",
    "href": "http://stock.jrj.com.cn/2019/03/14000027166150.shtml",
    "datetime": "2019-03-14 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药股东旺典投资减持583万股 套现约7360万元",
    "href": "http://stock.jrj.com.cn/2019/03/12075427152142.shtml",
    "datetime": "2019-03-12 07:54:15",
    "code": "300705"
  },
  {
    "title": "九典制药5名股东合计减持235万股 套现约3546万元",
    "href": "http://stock.jrj.com.cn/2019/03/12074727152113.shtml",
    "datetime": "2019-03-12 07:47:33",
    "code": "300705"
  },
  {
    "title": "[九典制药]仿制药一致性评价首战告捷 我司盐酸左西替利嗪片通过一致性评价",
    "href": "http://stock.jrj.com.cn/2019/02/21000027071968.shtml",
    "datetime": "2019-02-21 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药：盐酸左西替利嗪片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/02/18174227056151.shtml",
    "datetime": "2019-02-18 17:42:00",
    "code": "300705"
  },
  {
    "title": "九典制药五名股东拟合计减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/02/12195227035361.shtml",
    "datetime": "2019-02-12 19:52:46",
    "code": "300705"
  },
  {
    "title": "九典制药：多名股东拟合计减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/02/12193027035305.shtml",
    "datetime": "2019-02-12 19:30:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典制药喜迁新址 不忘初心再战新征程",
    "href": "http://stock.jrj.com.cn/2018/12/07000025470106.shtml",
    "datetime": "2018-12-07 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典制药喜迁新址 不忘初心再战新征程",
    "href": "http://stock.jrj.com.cn/2018/12/07000027775672.shtml",
    "datetime": "2018-12-07 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药多位股东披露减持计划",
    "href": "http://stock.jrj.com.cn/2018/11/16211825360083.shtml",
    "datetime": "2018-11-16 21:18:49",
    "code": "300705"
  },
  {
    "title": "九典制药：旺典投资计划减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2018/11/16173125358885.shtml",
    "datetime": "2018-11-16 17:31:00",
    "code": "300705"
  },
  {
    "title": "九典制药3名股东合计减持235万股 权益变动后持股比例合计为2.55%",
    "href": "http://stock.jrj.com.cn/2018/11/09101825322403.shtml",
    "datetime": "2018-11-09 10:18:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典参展第81届API China(南京)交易会",
    "href": "http://stock.jrj.com.cn/2018/10/31000025285111.shtml",
    "datetime": "2018-10-31 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典携肝复乐胶囊参展甘肃省医师协会感染科医师分会第三届学术年会",
    "href": "http://stock.jrj.com.cn/2018/10/31000025285112.shtml",
    "datetime": "2018-10-31 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药股东拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2018/10/15184025205558.shtml",
    "datetime": "2018-10-15 18:40:57",
    "code": "300705"
  },
  {
    "title": "九典制药：股东拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2018/10/15175525205342.shtml",
    "datetime": "2018-10-15 17:55:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典胶体果胶铋干混悬剂、克霉唑阴道片获药品注册批件",
    "href": "http://stock.jrj.com.cn/2018/08/23000024992758.shtml",
    "datetime": "2018-08-23 00:00:00",
    "code": "300705"
  },
  {
    "title": "午后医药股异动拉升 九典制药涨停",
    "href": "http://stock.jrj.com.cn/2018/07/11144524799919.shtml",
    "datetime": "2018-07-11 14:45:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典制药牵手湖南中医药大学“三下乡”送健康",
    "href": "http://stock.jrj.com.cn/2018/06/23000024992759.shtml",
    "datetime": "2018-06-23 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]长沙市委副书记、市长胡忠雄调研九典制药",
    "href": "http://stock.jrj.com.cn/2018/06/06000024992760.shtml",
    "datetime": "2018-06-06 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典制药望城基地喜获首张GMP证书",
    "href": "http://stock.jrj.com.cn/2018/06/05000024992756.shtml",
    "datetime": "2018-06-05 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典盐酸左西替利嗪口服溶液喜获生产批文",
    "href": "http://stock.jrj.com.cn/2018/05/25000024992757.shtml",
    "datetime": "2018-05-25 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典硝呋太尔阴道片喜获生产批文 实现公司妇科外用抗感染药物领域新突破",
    "href": "http://stock.jrj.com.cn/2018/05/21000024992754.shtml",
    "datetime": "2018-05-21 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典亮相重庆医学会风湿学术年会 洛索洛芬钠凝胶膏疗效获专家认可",
    "href": "http://stock.jrj.com.cn/2018/05/21000024992761.shtml",
    "datetime": "2018-05-21 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药：盐酸左西替利嗪口服溶液获注册批件",
    "href": "http://stock.jrj.com.cn/2018/05/16215024550171.shtml",
    "datetime": "2018-05-16 21:50:00",
    "code": "300705"
  },
  {
    "title": "九典制药获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2018/05/16163524548897.shtml",
    "datetime": "2018-05-16 16:35:00",
    "code": "300705"
  },
  {
    "title": "医药股涨幅扩大 九典制药等多只个股涨停",
    "href": "http://stock.jrj.com.cn/2018/05/16134024547870.shtml",
    "datetime": "2018-05-16 13:40:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典制药亮相国际展会 新产品新面貌引人瞩目",
    "href": "http://stock.jrj.com.cn/2018/05/03000027609723.shtml",
    "datetime": "2018-05-03 00:00:00",
    "code": "300705"
  },
  {
    "title": "妖股回头接力 九典制药2连板",
    "href": "http://stock.jrj.com.cn/2018/04/25143424449336.shtml",
    "datetime": "2018-04-25 14:34:01",
    "code": "300705"
  },
  {
    "title": "妖股行情轰然倒塌 九典制药封跌停",
    "href": "http://stock.jrj.com.cn/2018/04/12143824380763.shtml",
    "datetime": "2018-04-12 14:38:24",
    "code": "300705"
  },
  {
    "title": "强势股午后补跌 阿科力、九典制药等集体跌停",
    "href": "http://stock.jrj.com.cn/2018/04/12140424380585.shtml",
    "datetime": "2018-04-12 14:04:14",
    "code": "300705"
  },
  {
    "title": "昨日神奇不在 九典制药今日价格大幅下行",
    "href": "http://stock.jrj.com.cn/2018/04/11145824374785.shtml",
    "datetime": "2018-04-11 14:58:47",
    "code": "300705"
  },
  {
    "title": "龙虎榜:次新+医药再出九典制药强股 孙煜+小鳄鱼共板",
    "href": "http://stock.jrj.com.cn/hotstock/2018/04/10223924370384.shtml",
    "datetime": "2018-04-10 22:39:30",
    "code": "300705"
  },
  {
    "title": "妖股狂欢进行时 九典制药3连板",
    "href": "http://stock.jrj.com.cn/2018/04/10102424366986.shtml",
    "datetime": "2018-04-10 10:24:13",
    "code": "300705"
  },
  {
    "title": "次新板块午后走强 九典制药2连板",
    "href": "http://stock.jrj.com.cn/2018/04/09144424362282.shtml",
    "datetime": "2018-04-09 14:44:37",
    "code": "300705"
  },
  {
    "title": "两大强势板块叠加 九典制药午后直线涨停",
    "href": "http://stock.jrj.com.cn/2018/04/04140124350999.shtml",
    "datetime": "2018-04-04 14:01:58",
    "code": "300705"
  },
  {
    "title": "九典制药：拟不超3000万元购买房产",
    "href": "http://stock.jrj.com.cn/hotstock/2018/03/29075924319304.shtml",
    "datetime": "2018-03-29 07:59:50",
    "code": "300705"
  },
  {
    "title": "[天眼]九典制药拟高送转遭深交所关注 预案披露前2日涨停今日三连板",
    "href": "http://stock.jrj.com.cn/2018/03/22182124280699.shtml",
    "datetime": "2018-03-22 18:21:24",
    "code": "300705"
  },
  {
    "title": "九典制药2017年度利润分配拟10转10派1.2元",
    "href": "http://stock.jrj.com.cn/2018/03/21200124274734.shtml",
    "datetime": "2018-03-21 20:01:00",
    "code": "300705"
  },
  {
    "title": "九典制药实控人提议年报10转10派1.2元",
    "href": "http://stock.jrj.com.cn/2018/03/21195224274671.shtml",
    "datetime": "2018-03-21 19:52:35",
    "code": "300705"
  },
  {
    "title": "医药股继续走强 盘龙药业、九典制药双双封涨停",
    "href": "http://stock.jrj.com.cn/2018/03/20095924265430.shtml",
    "datetime": "2018-03-20 09:59:52",
    "code": "300705"
  },
  {
    "title": "快讯：医药股早盘快速拉升 九典制药涨停",
    "href": "http://stock.jrj.com.cn/2018/03/20094624265347.shtml",
    "datetime": "2018-03-20 09:46:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]九典OTC事业部举行创中药养生新品牌新闻发布会",
    "href": "http://stock.jrj.com.cn/2018/03/07000024203946.shtml",
    "datetime": "2018-03-07 00:00:00",
    "code": "300705"
  },
  {
    "title": "[九典制药]寒冬里的一股暖流 九典制药为儿童融合基地捐赠抗流感药物",
    "href": "http://stock.jrj.com.cn/2018/02/02000024051276.shtml",
    "datetime": "2018-02-02 00:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药全资子公司收到政府补贴1997万元",
    "href": "http://stock.jrj.com.cn/2017/11/29183623715319.shtml",
    "datetime": "2017-11-29 18:36:00",
    "code": "300705"
  },
  {
    "title": "九典制药和威唐工业今日上市交易",
    "href": "http://stock.jrj.com.cn/ipo/2017/10/10065423208409.shtml",
    "datetime": "2017-10-10 06:54:28",
    "code": "300705"
  },
  {
    "title": "九典制药9月21日申购宝典",
    "href": "http://stock.jrj.com.cn/ipo/2017/09/20134523142915.shtml",
    "datetime": "2017-09-20 13:45:40",
    "code": "300705"
  },
  {
    "title": "九典制药IPO：募资3.3亿加码主业 3年获税收优惠逾1700万",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/24170022789763.shtml",
    "datetime": "2017-07-24 17:00:00",
    "code": "300705"
  },
  {
    "title": "九典制药IPO：募资3.3亿加码主业 3年获税收优惠逾1700万",
    "href": "http://stock.jrj.com.cn/ipo/2017/07/24170022858173.shtml",
    "datetime": "2017-07-24 17:00:00",
    "code": "300705"
  },
  {
    "title": "湖南九典制药股份有限公司创业板首次公开发行股票招股说明书（申报稿2017年7月21日报送）",
    "href": "http://stock.jrj.com.cn/2017/07/21193822782905.shtml",
    "datetime": "2017-07-21 19:38:32",
    "code": "300705"
  },
  {
    "title": "九典制药2016年营收3.76亿元 同比增长30%",
    "href": "http://stock.jrj.com.cn/2017/04/14144222319353.shtml",
    "datetime": "2017-04-14 14:42:57",
    "code": "300705"
  },
  {
    "title": "九典制药2016年净利润5453万元 同比增长22%",
    "href": "http://stock.jrj.com.cn/2017/04/11220022297859.shtml",
    "datetime": "2017-04-11 22:00:00",
    "code": "300705"
  }
]